Advertisement
Monday, Oct 18, 2021
Outlook.com
Outlook.com

Biological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial On Children, Adolescents

Mahima Datla, Managing Director, Biological E. Limited, said these approvals would help support its subsequent filings with the World Health Organization (WHO) as well.

Biological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial  On Children, Adolescents
Representational Image | PTI
Biological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial On Children, Adolescents
outlookindia.com
2021-09-03T22:13:12+05:30

Department of Biotechnology on Friday confirmed approval for phase II/III human clinical trial of Biological E's COVID-19 vaccine candidate Corbevax  which are to be conducted on children above five years and adolescents.

Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council (BIRAC) have acted in concert to develop the RBD protein sub-unit vaccine Corbevax.

 Drugs Controller General of India (DCGI) issued approval for conducting phase III comparator safety and immunogenicity trial in adults following Subject Expert Committee's (SEC) review of Phase I and II clinical trials data.

"Additionally, Biological E also received approval on 01.09.2021 to initiate Phase II/III study to evaluate safety, reactogenicity, tolerability and immunogenicity of Corbevax vaccine in children and adolescents," the DBT said.

Mahima Datla, Managing Director, Biological E. Limited, said these approvals would help support its subsequent filings with the World Health Organization (WHO) as well.

So far indigenously developed Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country.

The DCGI in July had granted permission to the Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions. 

The development of Corbevax was supported by the Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council (BIRAC) from preclinical stage to phase III clinical studies, the DBT said.

"We look forward to the clinical development of candidate Corbevax for paediatric and adults,” DBT Secretary Renu Swarup said. 

Datla said, “We are delighted to receive these significant approvals from the DCGI. These approvals encourage our organisation to move forward and successfully produce our COVID-19 vaccine to meet the vaccination needs.

“We are grateful to BIRAC for their support and we are enthused that these approvals would help support our subsequent filings with WHO as well. We appreciate and acknowledge the contribution of all our collaborators for their continued support in this endeavour," Datla said. 

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lakhimpur Violence: SKM To Hold 'Rail Roko' Today Demanding Arrest Of Union Minister Ajay Mishra

Lakhimpur Violence: SKM To Hold 'Rail Roko' Today Demanding Arrest Of Union Minister Ajay Mishra

The SKM said all train traffic will be stopped for six hours from 10 am till 4 pm during the 'rail roko' protest on Monday.

EAM Jaishankar Visits Israel: Says Health, Tech, Green Growth Natural Areas Of Collaboration

EAM Jaishankar Visits Israel: Says Health, Tech, Green Growth Natural Areas Of Collaboration

Jaishankar, on his Israel visit, met the Jewish community, met the Chambers of commerce, and will also call on Israeli President, PM and FM soon.

Mahmudullah Calls For Urgent Introspection After Scotland Loss

Mahmudullah Calls For Urgent Introspection After Scotland Loss

This was Scotland's second win in a T20 World Cup, the first coming in the 2016 edition of the tournament against Hong Kong.

India Strengthens Day And Night Surveillance Over LAC In Arunachal Sector

India Strengthens Day And Night Surveillance Over LAC In Arunachal Sector

India has strengthened overall military preparedness at LAC using a fleet of remotely piloted aircraft and other assets to deal with any Chinese misadventure in the sector.

Advertisement